Consumer Research
TerrAscend Reports Q1 2026 Financial Results
TORONTO – TerrAscend Corp. announced financial results for the first ...
Trulieve Reports Q1 2026 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. entered 2026 with a first ...
Compass Pathways Advances in Second Phase 3 Trial for Psilocybin-Assisted TRD
LONDON – Compass Pathways PLC ADR, a UK-based mental health biotech company, announced that its second Phase 3 trial met the primary endpoint in evaluating COMP360, a synthetic formulation of psilocybin, for treatment-resistant depression (TRD). ...
350 Retail Cap and Tier V Cultivation Limits: What Virginia’s Scarcity Model Means for License Strategy
RICHMOND- Virginia’s adult-use design is built on scarcity and structural oversight. The 350 retail cap materially limits market density, shaping site selection and long-term valuation models. Tier V cultivation remains limited to five large operators. ...
Virginia Adult-Use Applications Expected in 2026: Operators Should Begin Structuring Now
NEW YORK- Virginia’s adult-use Cannabis legislation is now in reconciliation after both the House (HB 642) and Senate (SB 542) advanced competing sales frameworks. For operators, the question is no longer whether retail will launch—but ...
How to Make the Most of MJBizCon? Take Full Advantage of LinkedIn
LOS ANGELES- Each year, the global Cannabis industry converges on Las Vegas for MJBizCon Dec 2-5 in the Las Vegas Convention Center—a concentrated, high-value moment where operators, investors, executives, retailers, lenders, lawyers, accountants, manufacturers, and ...
New Jersey Assembly Panel Clears Path for Psilocybin Therapy Program
TRENTON – New Jersey lawmakers advanced a bill that would allow supervised access to psilocybin for adults facing certain health challenges, establishing a regulated psilocybin therapy framework approved by the Assembly Health Committee. Assemblymember Anthony ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators and investors in Cannabis and Psychedelics faced a week of sharp contrasts. Federal action ended the longest government shutdown on record, yet it delivered a body blow to hemp-derived products that ...
Europe Advances Psychedelic Medicine with Targeted Approvals in Three Nations
BERLIN – Switzerland's long-standing framework for psychedelic treatments has set a course for its neighbors, as Germany and the Czech Republic roll out their own programs to address stubborn mental health conditions. These steps mark ...
As November Looms, the Intoxicating Hemp Industry Carries On — Calmly, Confidently, and Perhaps Optimistically
NEW YORK - Across the United States, the intoxicating hemp sector is behaving as though November 2026 is just another month on the calendar — not a potential regulatory cliff. That’s when new federal restrictions, ...
OPINION: The Cannabis Industry That Left Black America Behind
LOS ANGELES- America’s legal Cannabis industry loves to tell a redemption story: a plant once criminalized is now regulated, normalized, and generating billions in tax revenue. But redemption for whom? Black History Month shouldn’t just ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The Cannabis and Psychedelics sectors remain in a state of flux, balancing regulatory progress, market milestones, and corporate maneuvers with persistent challenges. Mature markets posted impressive revenue numbers, major operators strengthened their ...
